CBS 2019
CBSMD教育中心
English

IVUS Guidance

科研文章

荐读文献

Impact of plaque components on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome: a virtual histology-intravascular ultrasound analysis Intravascular ultrasound predictors for edge restenosis after newer generation drug-eluting stent implantation Comprehensive intravascular ultrasound assessment of stent area and its impact on restenosis and adverse cardiac events in 403 patients with unprotected left main disease Effects of Intravascular Ultrasound-Guided Versus Angiography-Guided New-Generation Drug-Eluting Stent Implantation: Meta-Analysis With Individual Patient-Level Data From 2,345 Randomized Patients Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients Intravascular ultrasound-guided vs angiography-guided drug-eluting stent implantation in complex coronary lesions: Meta-analysis of randomized trials Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial A three-vessel virtual histology intravascular ultrasound analysis of frequency and distribution of thin-cap fibroatheromas in patients with acute coronary syndrome or stable angina pectoris Differential prognostic effect of intravascular ultrasound use according to implanted stent length Impact of intravascular ultrasound guidance in routine percutaneous coronary intervention for conventional lesions: data from the EXCELLENT trial

JOURNAL:CBS2017 Article Link

向世界发出中国心声——TCT2017系列报道一

CBS2017


美国丹佛——当地时间1029日上午11001130分, Peter Block医生在TCT(经导管心血管治疗学术会议)的举办地Colorado Convention CenterACCEL办公室对远赴重洋,来自中国的DK Crush系列研究负责人陈绍良教授进行了一次深入的专访。此次访问紧密围绕DKCRUSH-V 对治疗冠脉左主干动脉真性远端分叉病变的双对吻挤压技术 (the double kissing crush techniques)与单支架技术(provisional side branch stenting)这一大规模多中心临床随机对照试验展开。






介入器械的日趋成熟并未彻底攻克冠脉分叉病变这一心血管重大疾病难点,不同的治疗策略亟需高信度、高水平的试验设计进行比较,并进一步接受全球临床的实战检验。为此,陈绍良团队历时十载,一直致力于此,持之以恒地探索治疗左主干分叉病变的可靠疗法,期待我国的创新可以为全球病患带去福音。






TCT2017重要日程预告



TCT2017作为冠脉左主干病变处理、生物可吸收支架、经导管瓣膜病治疗领域的顶尖专业盛会,将汇集12项最新揭晓临床试验(LBCTs)和16项首次报道研究(FRIs)结果在本次大会上揭晓。南京市第一医院陈绍良教授团队的DKCRUSH-V研究作为最值得关注的成果之一,将于当地时间10301140分(北京时间111日凌晨140分)在TCT2017主会场发布。南京市第一医院将分别于当地时间111日上午8时在主会场和10:00在冠脉分会场进行前后两次手术转播,分别演示经皮肺动脉去交感神经术(PADN)治疗原发性肺动脉高压、双对吻挤压术治疗左主干末端分叉病变技术,两场手术均由陈绍良教授担任主要术者。